Suzanne Crowe

CIK: 0001816242

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RCEL

AVITA Medical, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

RCEL
AVITA Medical, Inc.
Jan 20, 2026
Award(A)
Direct
22.2K shares-
RCEL
AVITA Medical, Inc.
Jan 21, 2025
Award(A)
Direct
10K shares-
RCEL
AVITA Medical, Inc.
Dec 9, 2024
Purchase(P)
Direct
486 shares at avg. $13.15$6K

		Type	Shares	Price		Ownership
Jan 20, 2026	RCEL AVITA Medical, Inc.	Award(A)	22,214	-	$0	Direct
Jan 21, 2025	RCEL AVITA Medical, Inc.	Award(A)	10,022	-	-	Direct
Dec 9, 2024	RCEL AVITA Medical, Inc.	Purchase(P)	486	$13.15	$6,391	Direct

1-3 of 3 transactions

About Crowe Suzanne

Crowe Suzanne (SEC CIK 0001816242) files insider reports with the SEC as Director of AVITA Medical, Inc. (RCEL).

Signal8 holds 3 ownership filings by Crowe Suzanne, all Form 4s, filed between Jan 29, 2025 and Jun 4, 2026. Those filings report 3 transactions, from Dec 9, 2024 to Jan 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Crowe Suzanne's filings is in VALENCIA, CA.

Recent filings by Crowe Suzanne

Jan 20, 2026: Grant or award of RCEL shares (Form 4, code A).
Jan 21, 2025: Grant or award of RCEL shares (Form 4, code A).
Dec 9, 2024: Open-market purchase of RCEL shares (Form 4, code P).

Other insiders filing for AVITA Medical, Inc. (RCEL)

How to read Form 4 transaction codes